Skip to main content

Table 3 Cox regression analysis for the prediction of biochemical recurrence in all patients from two academic centres

From: Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate

  All patients (n = 293, 69 BCR)
Hazard ratio (95% CI) P
Intraductal carcinoma of prostate 2.39 (1.44–3.97) 0.001
Adjuvant radiation therapy 0.38 (0.17–0.85) 0.018
Grade group 1.28 (1.00–1.62) 0.046
Extraprostatic extension 1.84 (1.07–3.15) 0.027
Positive margins 2.12 (1.28–3.50) 0.003
Seminal vesicle invasion 1.35 (0.67–2.69) 0.400
  1. IDC-P Intraductal carcinoma of the prostate, CI Confidence interval